Home arrow Ovarian Cancer arrow Diagnosis of Anal Cancer Wednesday, 19 November 2008



 
Slick RSS
MedicineNet Cancer General
MedicineNet Cancer General
MedicineNet Logo
MedicineNet Depression General
MedicineNet Depression General
MedicineNet Logo
Cancer / Oncology News From Medical News Today
Latest Cancer / Oncology News From Medical News Today.
  • PharmaMar Receives "Supporting A Cure In Our Time" Sarcoma Foundation Of America Award For Commitment With Research In Soft Tissue Sarcoma
    PharmaMar has received the Award "Supporting A Cure In Our Time" from the Sarcoma Foundation of America (SFA) for its "support in the search for an effective cure for soft tissue sarcomas," goal of the foundation, during the congress of the Connective Tissue Oncology Society (CTOS) held in London from 13-15 November.
  • ZIOPHARM Oncology Presents Positive Data From Studies Of Palifosfamide
    ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from a Phase I study of palifosfamide (ZymafosTM) in combination with doxorubicin at the 14th Annual Connective Tissue Oncology Society (CTOS) meeting held in London, UK, November 13 to 15. Also presented was an update of the data from the Phase II trial of palifosfamide used as a single agent in advanced sarcoma.
  • Metastatic Melanoma - Provectus Adds 6th Center To Phase 2 Clinical Trial Of PV-10
    Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a sixth major center located at the California Pacific Medical Center, in San Francisco, CA. David Minor, M.D. will serve as principal investigator at the new center covering the western United States.
  • Cancer Drug Avastin Raised Risk Of Blood Clots, Study
    A new analysis of randomized controlled trials of the widely used new generation cancer drug bevacizumab (marketed by Roche and Genentech as Avastin) found it was linked to an increased risk of deep vein blood clots or venous thromboembolism in the legs or lungs compared with treatments that did not use it.
  • Two New Compounds Show Promise For Destroying Breast Cancer Tumors - University Of Central Florida
    Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Associate Professor James Turkson's compounds disrupt the formation and spread of breast cancer tumors in tests on mice. The compounds, S3I-201 and S3I-M2001, break up a cancer-causing protein called STAT3, and researchers have observed no negative side effects so far. ...